Insider · CIK 0001752467
Ashu Tyagi
Files at YMAB (Y-mAbs Therapeutics, Inc.). First filing -, latest -.
Ashu Tyagi files SEC Form 4 as director at YMAB (Y-mAbs Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ashu Tyagi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | UTender of shares Common Stock | -5,825 | $8.60 | $50k | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Common Stock | -25,080 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -16,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -32,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -11,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -11,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -16,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -13,950 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -14,545 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -33,450 | - | - | 0 | Sep 18, 2025 |
| Jun 30, 2025 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +25,080 | $0.00 | $0 | 30,905 | Jul 2, 2025 |
| Jun 30, 2025 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +33,450 | $0.00 | $0 | 33,450 | Jul 2, 2025 |
Questions about Ashu Tyagi
Answered from the filings on this page, as of the latest one.
Is Ashu Tyagi buying or selling?
Ashu Tyagi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ashu Tyagi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ashu Tyagi has 0.
Where does Ashu Tyagi file Form 4?
Ashu Tyagi has filed Form 4 at YMAB (Y-mAbs Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.